Saturday
February 9, 2013
Monday, October 15, 2012

Meningitis outbreak expands to 15 states with Pennsylvania case

A fungal meningitis outbreak linked to contaminated steroid injections expanded to 15 states as Pennsylvania reported its first case of the disease that has killed 15 people nationwide.

The Pennsylvania patient, who received an epidural steroid injection in July from medications supplied by New England Compounding Center (NECC) of Framingham, Massachusetts, is
being treated in a hospital, the Pennsylvania Department of Health said.

The new case means that all but eight of the 23 states that received suspect medications from the Massachusetts specialist pharmacy have reported at least one case of fungal meningitis, a rare and deadly disease that has proven difficult to treat.

Over the weekend the Centers for Disease Control and Prevention said its tally of cases, which sometimes lags reports from state health departments, showed 205 people stricken with the disease after receiving injections. Illinois and New Hampshire reported their first cases.

The suspect lots of steroid were shipped to 76 facilities in 23 states, including two locations in Pennsylvania.

Health authorities believe that nearly 14,000 people nationwide received injections from the potentially contaminated medication.

The state worst affected by the outbreak, Tennessee with 53 cases and six deaths, was holding an administrative hearing to determine whether to suspend the license of NECC.


  • CommentComment
  • Increase font size Decrease font sizeSize
  • Email article
    email
  • Print
    Print
  • Share
    1. Vote
    2. Not interesting Little interesting Interesting Very interesting Indispensable
Tags:  Meningitis  Pennsylvania  outbreak  US  medications  


  • Comment
  • Increase font size Decrease font size
  • mail
  • Print

COMMENTS >

Comment



Grupo ámbito ámbito financiero ambito.com Docsalud AlRugby.com Premium ávp El Ciudadano El Tribuno Management

Director: Orlando Mario Vignatti - Edition No. 3676 - This publication is a property of NEFIR S.A. - Issn 1852 - 9224 - Te. 4349-1500 - Paseo Colón 1196, (C1063ACY) CABA